osimertinib
astrazeneca
['osimertinib']
 osimertinib probably needs chemo in this setting to maximize any benefit. i don t think there is a strong biological rationale for neoadj tki (as compared to neoadjuvant io) but there are scenarios eg stage 3 disease where neoadj tki-chemo makes some sense.
Lung cancer & Mesothelioma @HopkinsThoracic @HopkinsKimmel Immunotherapy believer. 🇮🇪 🇺🇸